Myelodysplastic Syndromes Foundation
EIN: 223283911 · New York, NY · NTEE: G30
| Metric | Value |
|---|---|
| Total Revenue | $2.1M |
| Total Expenses | $3.1M |
| Net Assets | $4.7M |
Is Myelodysplastic Syndromes Foundation Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Myelodysplastic Syndromes Foundation
Myelodysplastic Syndromes Foundation (EIN: 223283911) is a nonprofit organization based in New York, NY, classified under NTEE code G30. The organization reported total revenue of $2.1M and total assets of $3.8M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Myelodysplastic Syndromes Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Myelodysplastic Syndromes Foundation is a mid-size nonprofit that has been operating for 26 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -1.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.7M |
| Total Expenses | $3.1M |
| Surplus / Deficit | $-394,879 |
| Total Assets | $5.2M |
| Total Liabilities | $470K |
| Net Assets | $4.7M |
| Operating Margin | -14.4% |
| Debt-to-Asset Ratio | 9.0% |
| Months of Reserves | 19.9 months |
Financial Health Grade: B
In 2023, Myelodysplastic Syndromes Foundation reported a deficit of $395K with expenses exceeding revenue, holds 19.9 months of operating reserves (strong position), has a debt-to-asset ratio of 9.0% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Myelodysplastic Syndromes Foundation's revenue has declined at a compound annual growth rate (CAGR) of -1.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +9.0% | +44.6% | -3.8% |
| 2022 | -45.9% | -22.8% | +3.5% |
| 2021 | +41.7% | +40.0% | +59.9% |
| 2020 | +13.0% | -15.3% | +66.1% |
| 2019 | +90.0% | +98.1% | +57.3% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2000 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Myelodysplastic Syndromes Foundation has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Myelodysplastic Syndromes Foundation with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $395K, with expenses exceeding revenue.
- Debt-to-asset ratio: 9.0%.
Frequently Asked Questions about Myelodysplastic Syndromes Foundation
Is Myelodysplastic Syndromes Foundation a legitimate charity?
Myelodysplastic Syndromes Foundation (EIN: 223283911) is a registered tax-exempt nonprofit based in New York. It has 13 years of IRS 990 filings on record. Total revenue: $2.1M. No red flags identified. Financial health grade: B.
How does Myelodysplastic Syndromes Foundation spend its money?
Myelodysplastic Syndromes Foundation reported $2.1M in total revenue in IRS 990 filings. 13 years of filing data available. Expenses exceeded revenue in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Myelodysplastic Syndromes Foundation tax-deductible?
Myelodysplastic Syndromes Foundation is registered as a tax-exempt nonprofit (EIN: 223283911). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Myelodysplastic Syndromes Foundation located?
Myelodysplastic Syndromes Foundation is headquartered in New York, New York and files with the IRS under EIN 223283911. It is classified under NTEE code G30.
How many years of IRS 990 filings does Myelodysplastic Syndromes Foundation have?
Myelodysplastic Syndromes Foundation has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.1M in total revenue.
Filing History
IRS 990 filing history for Myelodysplastic Syndromes Foundation showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Myelodysplastic Syndromes Foundation's revenue has declined by 11%, moving from $3.1M to $2.7M. Total assets increased by 1280.8% over the same period, from $378K to $5.2M. Total functional expenses rose by 41.6%, from $2.2M to $3.1M. In its most recent filing year (2023), Myelodysplastic Syndromes Foundation reported a deficit of $395K, with expenses exceeding revenue. The organization holds $470K in liabilities against $5.2M in assets (debt-to-asset ratio: 9.0%), resulting in net assets of $4.7M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.7M | $3.1M | $5.2M | $470K | — | — |
| 2022 | $2.5M | $2.2M | $5.4M | $281K | — | View 990 |
| 2021 | $4.7M | $2.8M | $5.2M | $446K | — | View 990 |
| 2020 | $3.3M | $2.0M | $3.3M | $338K | — | — |
| 2019 | $2.9M | $2.4M | $2.0M | $308K | — | View 990 |
| 2018 | $1.5M | $1.2M | $1.3M | $121K | — | View 990 |
| 2017 | $3.9M | $3.3M | $2.1M | $1.3M | — | View 990 |
| 2016 | $937K | $1.1M | $368K | $136K | — | View 990 |
| 2015 | $2.7M | $2.8M | $659K | $224K | — | View 990 |
| 2014 | $1.2M | $1.4M | $639K | $86K | — | View 990 |
| 2013 | $1.4M | $1.2M | $926K | $167K | — | View 990 |
| 2012 | $1.6M | $1.1M | $727K | $112K | — | View 990 |
| 2011 | $3.1M | $2.2M | $378K | $251K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.7M, expenses of $3.1M, and assets of $5.2M (revenue +9.0% year-over-year).
- 2022: Revenue of $2.5M, expenses of $2.2M, and assets of $5.4M (revenue -45.9% year-over-year).
- 2021: Revenue of $4.7M, expenses of $2.8M, and assets of $5.2M (revenue +41.7% year-over-year).
- 2020: Revenue of $3.3M, expenses of $2.0M, and assets of $3.3M (revenue +13.0% year-over-year).
- 2019: Revenue of $2.9M, expenses of $2.4M, and assets of $2.0M (revenue +90.0% year-over-year).
- 2018: Revenue of $1.5M, expenses of $1.2M, and assets of $1.3M (revenue -60.7% year-over-year).
- 2017: Revenue of $3.9M, expenses of $3.3M, and assets of $2.1M (revenue +316.4% year-over-year).
- 2016: Revenue of $937K, expenses of $1.1M, and assets of $368K (revenue -65.2% year-over-year).
- 2015: Revenue of $2.7M, expenses of $2.8M, and assets of $659K (revenue +131.4% year-over-year).
- 2014: Revenue of $1.2M, expenses of $1.4M, and assets of $639K (revenue -14.3% year-over-year).
- 2013: Revenue of $1.4M, expenses of $1.2M, and assets of $926K (revenue -16.6% year-over-year).
- 2012: Revenue of $1.6M, expenses of $1.1M, and assets of $727K (revenue -47.4% year-over-year).
- 2011: Revenue of $3.1M, expenses of $2.2M, and assets of $378K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Myelodysplastic Syndromes Foundation:
Data Sources and Methodology
This transparency report for Myelodysplastic Syndromes Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.